Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lasers, Solid-State | 6 | 2022 | 175 | 2.630 |
Why?
|
Melanosis | 3 | 2022 | 93 | 2.170 |
Why?
|
Cosmetic Techniques | 4 | 2024 | 148 | 1.800 |
Why?
|
Acne Vulgaris | 3 | 2024 | 356 | 1.600 |
Why?
|
Lasers, Gas | 2 | 2023 | 94 | 1.530 |
Why?
|
Hyaluronic Acid | 3 | 2024 | 482 | 1.520 |
Why?
|
Skin | 17 | 2024 | 4464 | 1.490 |
Why?
|
Laser Therapy | 4 | 2022 | 1082 | 1.440 |
Why?
|
Lichen Planus | 2 | 2024 | 71 | 1.380 |
Why?
|
Lasers, Dye | 2 | 2020 | 28 | 1.300 |
Why?
|
Skin Diseases, Vesiculobullous | 2 | 2018 | 85 | 1.190 |
Why?
|
Skin Neoplasms | 11 | 2023 | 5799 | 1.140 |
Why?
|
Keloid | 3 | 2024 | 54 | 1.130 |
Why?
|
Drug Eruptions | 3 | 2018 | 335 | 1.120 |
Why?
|
Skin Aging | 5 | 2022 | 141 | 1.100 |
Why?
|
Hypopigmentation | 2 | 2023 | 43 | 1.090 |
Why?
|
Durapatite | 2 | 2024 | 163 | 1.040 |
Why?
|
Scalp Dermatoses | 2 | 2017 | 44 | 1.030 |
Why?
|
Dermatologic Agents | 3 | 2024 | 308 | 0.880 |
Why?
|
Cocaine | 2 | 2018 | 958 | 0.870 |
Why?
|
Lupus Erythematosus, Cutaneous | 1 | 2024 | 73 | 0.870 |
Why?
|
Skin Pigmentation | 2 | 2023 | 276 | 0.860 |
Why?
|
Skin Diseases | 4 | 2019 | 1088 | 0.840 |
Why?
|
Isotretinoin | 1 | 2024 | 132 | 0.840 |
Why?
|
Cicatrix | 4 | 2022 | 780 | 0.830 |
Why?
|
Dermatitis, Allergic Contact | 1 | 2024 | 111 | 0.830 |
Why?
|
Polyesters | 1 | 2024 | 370 | 0.810 |
Why?
|
Cicatrix, Hypertrophic | 2 | 2020 | 81 | 0.800 |
Why?
|
Prurigo | 1 | 2021 | 25 | 0.750 |
Why?
|
Needles | 1 | 2024 | 450 | 0.740 |
Why?
|
Chemexfoliation | 1 | 2020 | 11 | 0.730 |
Why?
|
Syringoma | 1 | 2020 | 8 | 0.720 |
Why?
|
Ecchymosis | 1 | 2020 | 32 | 0.710 |
Why?
|
Sweat Glands | 1 | 2020 | 33 | 0.710 |
Why?
|
Tranexamic Acid | 1 | 2022 | 176 | 0.700 |
Why?
|
Lipodystrophy | 1 | 2021 | 148 | 0.690 |
Why?
|
Collagen Type VII | 2 | 2010 | 22 | 0.690 |
Why?
|
Apocrine Glands | 1 | 2019 | 32 | 0.670 |
Why?
|
Nevus, Pigmented | 1 | 2021 | 221 | 0.660 |
Why?
|
Nevus | 1 | 2021 | 205 | 0.660 |
Why?
|
Pigmentation Disorders | 1 | 2019 | 105 | 0.650 |
Why?
|
Dilatation | 1 | 2020 | 307 | 0.630 |
Why?
|
Pityriasis Rubra Pilaris | 3 | 2016 | 18 | 0.620 |
Why?
|
Eyebrows | 1 | 2018 | 35 | 0.600 |
Why?
|
Hair Removal | 1 | 2018 | 40 | 0.590 |
Why?
|
Keratoacanthoma | 1 | 2017 | 33 | 0.580 |
Why?
|
Lipoma | 1 | 2019 | 292 | 0.570 |
Why?
|
Facial Dermatoses | 1 | 2017 | 85 | 0.560 |
Why?
|
Dermatitis, Atopic | 1 | 2024 | 716 | 0.560 |
Why?
|
Purpura | 1 | 2017 | 116 | 0.550 |
Why?
|
Lupus Erythematosus, Discoid | 1 | 2017 | 61 | 0.550 |
Why?
|
Carcinoma, Merkel Cell | 2 | 2023 | 321 | 0.540 |
Why?
|
Propensity Score | 1 | 2024 | 1887 | 0.540 |
Why?
|
Melanocytes | 2 | 2018 | 509 | 0.520 |
Why?
|
Alopecia | 1 | 2020 | 411 | 0.510 |
Why?
|
Hair Follicle | 1 | 2017 | 210 | 0.500 |
Why?
|
Melanoma | 6 | 2022 | 5690 | 0.490 |
Why?
|
Giant Cells | 1 | 2015 | 185 | 0.490 |
Why?
|
Carcinosarcoma | 1 | 2015 | 104 | 0.480 |
Why?
|
Dermoscopy | 2 | 2022 | 66 | 0.460 |
Why?
|
Sarcoidosis | 1 | 2019 | 520 | 0.450 |
Why?
|
Guanylate Cyclase | 2 | 2015 | 205 | 0.450 |
Why?
|
Dermatology | 1 | 2023 | 914 | 0.440 |
Why?
|
Skin Diseases, Papulosquamous | 1 | 2013 | 17 | 0.440 |
Why?
|
CARD Signaling Adaptor Proteins | 2 | 2015 | 159 | 0.430 |
Why?
|
Drug Delivery Systems | 2 | 2024 | 2211 | 0.430 |
Why?
|
Ear Auricle | 1 | 2013 | 31 | 0.430 |
Why?
|
Carcinoma, Squamous Cell | 3 | 2018 | 4021 | 0.420 |
Why?
|
Adipocytes | 1 | 2019 | 1178 | 0.410 |
Why?
|
Keratosis, Actinic | 1 | 2012 | 72 | 0.400 |
Why?
|
Osteoclasts | 1 | 2015 | 710 | 0.390 |
Why?
|
Administration, Cutaneous | 3 | 2024 | 711 | 0.380 |
Why?
|
Telomerase | 1 | 2015 | 745 | 0.360 |
Why?
|
Comorbidity | 2 | 2024 | 10478 | 0.350 |
Why?
|
Humans | 70 | 2024 | 757650 | 0.350 |
Why?
|
Epidermolysis Bullosa | 1 | 2010 | 29 | 0.340 |
Why?
|
Epidermolysis Bullosa Dystrophica | 1 | 2010 | 28 | 0.340 |
Why?
|
Digestive System Abnormalities | 1 | 2010 | 49 | 0.340 |
Why?
|
Epidermis | 2 | 2021 | 528 | 0.340 |
Why?
|
Pylorus | 1 | 2010 | 86 | 0.340 |
Why?
|
Collagen Type II | 1 | 2009 | 148 | 0.320 |
Why?
|
Triamcinolone | 2 | 2018 | 68 | 0.310 |
Why?
|
Sweet Syndrome | 1 | 2009 | 58 | 0.310 |
Why?
|
Lasers | 3 | 2020 | 951 | 0.310 |
Why?
|
Neoplasm Proteins | 1 | 2019 | 3608 | 0.280 |
Why?
|
Luminescent Proteins | 1 | 2009 | 835 | 0.280 |
Why?
|
Collagen Type I | 2 | 2019 | 616 | 0.270 |
Why?
|
Injections, Intravenous | 1 | 2009 | 1379 | 0.270 |
Why?
|
Psoriasis | 1 | 2014 | 938 | 0.260 |
Why?
|
Rejuvenation | 2 | 2022 | 106 | 0.260 |
Why?
|
Behcet Syndrome | 1 | 2005 | 86 | 0.240 |
Why?
|
Adult | 23 | 2024 | 219747 | 0.240 |
Why?
|
Amino Acid Substitution | 1 | 2009 | 1734 | 0.240 |
Why?
|
Promoter Regions, Genetic | 1 | 2015 | 5779 | 0.230 |
Why?
|
Green Fluorescent Proteins | 1 | 2009 | 2057 | 0.230 |
Why?
|
Fistula | 1 | 2005 | 212 | 0.230 |
Why?
|
Prednisone | 2 | 2018 | 1563 | 0.230 |
Why?
|
Treatment Outcome | 12 | 2022 | 64242 | 0.220 |
Why?
|
Internship and Residency | 1 | 2023 | 5854 | 0.220 |
Why?
|
Neovascularization, Pathologic | 1 | 2014 | 2638 | 0.220 |
Why?
|
Cysteamine | 1 | 2022 | 24 | 0.220 |
Why?
|
Immunoglobulins, Intravenous | 2 | 2007 | 664 | 0.220 |
Why?
|
Zinc Sulfate | 1 | 2022 | 18 | 0.220 |
Why?
|
Mutation | 5 | 2018 | 29928 | 0.220 |
Why?
|
Male | 29 | 2024 | 358227 | 0.210 |
Why?
|
Fibrosis | 4 | 2020 | 2038 | 0.210 |
Why?
|
Immunohistochemistry | 4 | 2023 | 11065 | 0.210 |
Why?
|
Biopsy, Needle | 2 | 2018 | 1627 | 0.210 |
Why?
|
Erythema | 1 | 2024 | 262 | 0.200 |
Why?
|
Cell Differentiation | 1 | 2019 | 11470 | 0.200 |
Why?
|
Middle Aged | 24 | 2024 | 219219 | 0.200 |
Why?
|
Nail Diseases | 1 | 2022 | 55 | 0.190 |
Why?
|
Stress, Physiological | 1 | 2009 | 1398 | 0.190 |
Why?
|
Head and Neck Neoplasms | 1 | 2015 | 2882 | 0.190 |
Why?
|
Rosacea | 1 | 2021 | 59 | 0.180 |
Why?
|
Communication Barriers | 1 | 2024 | 413 | 0.180 |
Why?
|
Ink | 1 | 2020 | 47 | 0.180 |
Why?
|
Administration, Oral | 3 | 2018 | 3995 | 0.180 |
Why?
|
Retrospective Studies | 9 | 2024 | 79982 | 0.170 |
Why?
|
Collagen | 1 | 2008 | 2634 | 0.170 |
Why?
|
Foot | 1 | 2024 | 573 | 0.170 |
Why?
|
Biopsy | 5 | 2021 | 6758 | 0.170 |
Why?
|
Female | 26 | 2024 | 389985 | 0.170 |
Why?
|
Granuloma Annulare | 1 | 2019 | 29 | 0.170 |
Why?
|
Diagnosis, Differential | 6 | 2022 | 12950 | 0.160 |
Why?
|
Candidiasis, Cutaneous | 1 | 2018 | 5 | 0.160 |
Why?
|
MART-1 Antigen | 1 | 2019 | 65 | 0.160 |
Why?
|
Scrotum | 1 | 2019 | 116 | 0.160 |
Why?
|
Dermis | 1 | 2020 | 202 | 0.160 |
Why?
|
Sulfonylurea Compounds | 1 | 2020 | 219 | 0.160 |
Why?
|
Neuromuscular Agents | 1 | 2020 | 148 | 0.160 |
Why?
|
Pemphigoid, Bullous | 1 | 2020 | 114 | 0.160 |
Why?
|
Permeability | 1 | 2020 | 718 | 0.160 |
Why?
|
Databases, Factual | 2 | 2024 | 7926 | 0.160 |
Why?
|
Myelodysplastic Syndromes | 1 | 2009 | 1392 | 0.160 |
Why?
|
Pigmentation | 1 | 2019 | 144 | 0.160 |
Why?
|
Elastic Tissue | 1 | 2018 | 65 | 0.150 |
Why?
|
Tranylcypromine | 1 | 2018 | 30 | 0.150 |
Why?
|
Neuropilin-2 | 1 | 2018 | 55 | 0.150 |
Why?
|
Aged | 17 | 2024 | 167889 | 0.150 |
Why?
|
Keratolytic Agents | 1 | 2017 | 34 | 0.150 |
Why?
|
Membrane Proteins | 2 | 2015 | 7841 | 0.150 |
Why?
|
Histocytological Preparation Techniques | 1 | 2017 | 33 | 0.140 |
Why?
|
Lichenoid Eruptions | 1 | 2017 | 13 | 0.140 |
Why?
|
Light | 1 | 2023 | 1345 | 0.140 |
Why?
|
Co-Repressor Proteins | 1 | 2018 | 191 | 0.140 |
Why?
|
Botulinum Toxins, Type A | 1 | 2020 | 229 | 0.140 |
Why?
|
Herpes Zoster | 1 | 2019 | 252 | 0.140 |
Why?
|
Nevus, Epithelioid and Spindle Cell | 1 | 2018 | 70 | 0.140 |
Why?
|
Administration, Topical | 1 | 2018 | 696 | 0.140 |
Why?
|
Antigens, CD34 | 1 | 2019 | 653 | 0.140 |
Why?
|
Emollients | 1 | 2016 | 41 | 0.130 |
Why?
|
NF-kappa B | 1 | 2015 | 2472 | 0.130 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2020 | 311 | 0.130 |
Why?
|
Thigh | 1 | 2017 | 241 | 0.130 |
Why?
|
Hair | 2 | 2018 | 497 | 0.130 |
Why?
|
Leg | 1 | 2020 | 1087 | 0.130 |
Why?
|
Keratitis | 1 | 2018 | 239 | 0.130 |
Why?
|
Atrophy | 1 | 2020 | 1627 | 0.120 |
Why?
|
Fibroblasts | 3 | 2019 | 4087 | 0.120 |
Why?
|
Skin Transplantation | 1 | 2020 | 1083 | 0.120 |
Why?
|
Back | 1 | 2014 | 64 | 0.120 |
Why?
|
Mohs Surgery | 1 | 2017 | 221 | 0.120 |
Why?
|
Language | 1 | 2024 | 1529 | 0.120 |
Why?
|
Actins | 2 | 2019 | 2049 | 0.110 |
Why?
|
Young Adult | 6 | 2024 | 58764 | 0.110 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2018 | 772 | 0.100 |
Why?
|
Lymphocytes | 1 | 2020 | 2611 | 0.100 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 786 | 0.100 |
Why?
|
Benzamides | 1 | 2018 | 1367 | 0.100 |
Why?
|
Thorax | 1 | 2014 | 553 | 0.090 |
Why?
|
Aged, 80 and over | 7 | 2019 | 58559 | 0.090 |
Why?
|
Adolescent | 7 | 2024 | 87832 | 0.090 |
Why?
|
Erbium | 1 | 2010 | 13 | 0.090 |
Why?
|
Photochemotherapy | 1 | 2017 | 819 | 0.090 |
Why?
|
Fibril-Associated Collagens | 1 | 2010 | 2 | 0.090 |
Why?
|
Regeneration | 1 | 2019 | 1505 | 0.080 |
Why?
|
Wound Healing | 1 | 2021 | 2781 | 0.080 |
Why?
|
Benzethonium | 1 | 2009 | 6 | 0.080 |
Why?
|
Paromomycin | 1 | 2009 | 14 | 0.080 |
Why?
|
Extremities | 1 | 2014 | 865 | 0.080 |
Why?
|
Bone Morphogenetic Protein 1 | 1 | 2008 | 11 | 0.080 |
Why?
|
Swine | 1 | 2019 | 5892 | 0.080 |
Why?
|
Antiprotozoal Agents | 1 | 2009 | 94 | 0.080 |
Why?
|
Risk Factors | 3 | 2024 | 73716 | 0.080 |
Why?
|
Xeroderma Pigmentosum | 1 | 2008 | 31 | 0.080 |
Why?
|
Granuloma, Pyogenic | 1 | 2008 | 47 | 0.070 |
Why?
|
Prognosis | 2 | 2018 | 29493 | 0.070 |
Why?
|
Prednisolone | 1 | 2009 | 326 | 0.070 |
Why?
|
Methotrexate | 1 | 2014 | 1718 | 0.070 |
Why?
|
Mice, Nude | 2 | 2018 | 3602 | 0.070 |
Why?
|
United States | 3 | 2024 | 71907 | 0.070 |
Why?
|
Neutrophils | 1 | 2020 | 3765 | 0.070 |
Why?
|
Orbit | 1 | 2010 | 446 | 0.070 |
Why?
|
Leishmaniasis, Cutaneous | 1 | 2009 | 136 | 0.070 |
Why?
|
Protein Stability | 1 | 2009 | 567 | 0.070 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1870 | 0.070 |
Why?
|
Immunoprecipitation | 1 | 2009 | 877 | 0.070 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2009 | 418 | 0.070 |
Why?
|
Time Factors | 5 | 2020 | 39815 | 0.070 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 11893 | 0.070 |
Why?
|
Hypertrichosis | 1 | 2006 | 31 | 0.070 |
Why?
|
Metalloendopeptidases | 1 | 2008 | 393 | 0.070 |
Why?
|
Pyridines | 1 | 2018 | 2864 | 0.060 |
Why?
|
Chronic Disease | 2 | 2018 | 9265 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2020 | 4902 | 0.060 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15773 | 0.060 |
Why?
|
Cell Line | 2 | 2009 | 15594 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2018 | 4406 | 0.060 |
Why?
|
DNA-Directed DNA Polymerase | 1 | 2008 | 489 | 0.060 |
Why?
|
Cohort Studies | 2 | 2024 | 41198 | 0.060 |
Why?
|
Myxedema | 1 | 2004 | 18 | 0.060 |
Why?
|
Vasculitis, Leukocytoclastic, Cutaneous | 1 | 2004 | 42 | 0.060 |
Why?
|
Hepatitis, Autoimmune | 1 | 2006 | 172 | 0.060 |
Why?
|
Injections, Intramuscular | 2 | 2020 | 553 | 0.060 |
Why?
|
Hidradenitis Suppurativa | 1 | 2007 | 173 | 0.060 |
Why?
|
Sclerosis | 1 | 2004 | 210 | 0.050 |
Why?
|
Merkel Cells | 1 | 2023 | 24 | 0.050 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2008 | 841 | 0.050 |
Why?
|
Temperature | 1 | 2009 | 2219 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2009 | 2646 | 0.050 |
Why?
|
Protein Structure, Tertiary | 1 | 2009 | 3795 | 0.050 |
Why?
|
Epitopes | 1 | 2008 | 2502 | 0.050 |
Why?
|
Child | 4 | 2024 | 79787 | 0.050 |
Why?
|
Dexamethasone | 1 | 2009 | 1927 | 0.050 |
Why?
|
Extracellular Matrix | 1 | 2008 | 1723 | 0.040 |
Why?
|
Inflammation | 1 | 2020 | 10718 | 0.040 |
Why?
|
Edema | 1 | 2004 | 769 | 0.040 |
Why?
|
Nails | 1 | 2022 | 295 | 0.040 |
Why?
|
Hyperplasia | 1 | 2023 | 1153 | 0.040 |
Why?
|
Risk Assessment | 2 | 2020 | 23819 | 0.040 |
Why?
|
Rare Diseases | 1 | 2015 | 618 | 0.040 |
Why?
|
Glucocorticoids | 1 | 2009 | 2145 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2019 | 116 | 0.040 |
Why?
|
Lenses | 1 | 2019 | 42 | 0.040 |
Why?
|
Models, Molecular | 1 | 2009 | 5411 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2015 | 1753 | 0.040 |
Why?
|
Hypertrophy | 1 | 2020 | 555 | 0.040 |
Why?
|
Esthetics | 1 | 2020 | 326 | 0.040 |
Why?
|
Procollagen | 1 | 2019 | 187 | 0.040 |
Why?
|
Fluconazole | 1 | 2018 | 155 | 0.040 |
Why?
|
Immunologic Factors | 1 | 2007 | 1584 | 0.040 |
Why?
|
Abdominal Wall | 1 | 2019 | 165 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2020 | 4845 | 0.040 |
Why?
|
Myofibroblasts | 1 | 2019 | 207 | 0.040 |
Why?
|
Connexins | 1 | 2018 | 351 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2020 | 12076 | 0.030 |
Why?
|
Salicylic Acid | 1 | 2016 | 62 | 0.030 |
Why?
|
Peptides | 1 | 2008 | 4340 | 0.030 |
Why?
|
Lower Extremity | 1 | 2024 | 1188 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2018 | 714 | 0.030 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2470 | 0.030 |
Why?
|
Renal Dialysis | 1 | 2004 | 1786 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 2018 | 923 | 0.030 |
Why?
|
Antifungal Agents | 1 | 2018 | 749 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2018 | 719 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10750 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2021 | 22024 | 0.030 |
Why?
|
Apoptosis | 1 | 2009 | 9469 | 0.030 |
Why?
|
Remission Induction | 1 | 2018 | 2391 | 0.030 |
Why?
|
Drug Design | 1 | 2018 | 1049 | 0.030 |
Why?
|
Hemorrhage | 1 | 2004 | 3399 | 0.030 |
Why?
|
Kidney Failure, Chronic | 1 | 2004 | 2455 | 0.020 |
Why?
|
Antibodies, Monoclonal | 1 | 2008 | 9163 | 0.020 |
Why?
|
Drug Prescriptions | 1 | 2020 | 1666 | 0.020 |
Why?
|
Phenotype | 2 | 2019 | 16533 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2015 | 14638 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3575 | 0.020 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2018 | 3774 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2018 | 6209 | 0.020 |
Why?
|
Child, Preschool | 2 | 2016 | 42044 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2015 | 15782 | 0.020 |
Why?
|
Mice | 2 | 2018 | 81107 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2018 | 2976 | 0.020 |
Why?
|
Codon, Nonsense | 1 | 2008 | 281 | 0.020 |
Why?
|
Asia | 1 | 2008 | 616 | 0.020 |
Why?
|
Animals | 3 | 2019 | 167777 | 0.020 |
Why?
|
Frameshift Mutation | 1 | 2008 | 388 | 0.020 |
Why?
|
Forearm | 1 | 2008 | 427 | 0.020 |
Why?
|
North America | 1 | 2008 | 1273 | 0.010 |
Why?
|
Age Factors | 1 | 2020 | 18328 | 0.010 |
Why?
|
Sentinel Lymph Node Biopsy | 1 | 2008 | 733 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21217 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2018 | 10416 | 0.010 |
Why?
|
Signal Transduction | 1 | 2015 | 23342 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16891 | 0.010 |
Why?
|
Europe | 1 | 2008 | 3415 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2017 | 5639 | 0.010 |
Why?
|
Pedigree | 1 | 2008 | 4578 | 0.010 |
Why?
|
Exanthema | 1 | 2004 | 505 | 0.010 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2008 | 2004 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2008 | 2565 | 0.010 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 2634 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2018 | 17767 | 0.010 |
Why?
|
Ultrasonography | 1 | 2008 | 5951 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13603 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7226 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2008 | 11083 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2008 | 12761 | 0.010 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2009 | 10135 | 0.010 |
Why?
|
Prospective Studies | 1 | 2016 | 54108 | 0.010 |
Why?
|
Positron-Emission Tomography | 1 | 2008 | 6457 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2007 | 39018 | 0.000 |
Why?
|
Infant | 1 | 2004 | 36043 | 0.000 |
Why?
|